Third Rock Ventures

Summary

Third Rock Ventures appeared to be the VC, which was created in 2007. The company was established in North America in United States. The main department of described VC is located in the Boston.

We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Foundation Medicine, Afferent Pharmaceuticals, Relay Therapeutics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.

The higher amount of exits for fund were in 2015. The real fund results show that this VC is 28 percentage points more often commits exit comparing to other companies. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 7-12 deals every year. This Third Rock Ventures works on 5 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2012. Despite it in 2019 the fund had an activity.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Third Rock Ventures, startups are often financed by Venrock, Flybridge Capital Partners, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are Flagship Pioneering, ARCH Venture Partners, Polaris Partners. In the next rounds fund is usually obtained by Wellington Management, Fidelity Management and Research Company, Venrock.

The current fund was established by Kevin Starr, Mark Levin, Robert Tepper. We also calculated 13 valuable employees in our database.